BPG is committed to discovery and dissemination of knowledge
Articles in Press
8/20/2026 8:42:45 AM | Browse: 10 | Download: 0
Publication Name World Journal of Clinical Oncology
Manuscript ID 123351
DOI 10.5306/wjco.123351
Country China
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Study
Article Title Neoadjuvant intra-arterial chemoembolization improves tumor pathological regression and survival in Borrmann type IV gastric cancer
Manuscript Source Unsolicited Manuscript
All Author List Xiao-Xing Wu, Hou-Dun Yang, Jiang Min, Chao Yuan, Lian-Shuo Li, Wei Zhang and Yue Tong
Funding Agency and Grant Number
Funding Agency Grant Number
Chongqing Municipal Science and Technology Bureau CSTB2025NSCQ-GPX1134
Corresponding Author Yue Tong, Academic Fellow, Department of Gastrointestinal Surgery, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing 400016, China. natual101@gmail.com
Key Words Borrmann type IV; Gastric cancer; Intra-arterial chemoembolization; Gastrectomy; Lymph node
Core Tip Borrmann type IV gastric cancer has a poor prognosis because of its diffuse and infiltrative growth pattern. In this retrospective cohort of 70 patients, neoadjuvant intra-arterial chemoembolization followed by gastrectomy achieved an objective response rate of 40.0% with manageable toxicity. Primary-tumor pathological response was associated with better survival in unadjusted analyses, whereas N-stage regression remained independently associated with improved overall survival and disease-free survival after multivariable adjustment. Postoperative complications were associated with worse outcomes. These findings support N-stage regression as a clinically relevant prognostic marker and warrant prospective evaluation of intra-arterial chemoembolization as a therapeutic strategy for Borrmann type IV gastric cancer.
Citation Wu XX, Yang HD, Min J, Yuan C, Li LS, Zhang W, Tong Y. Neoadjuvant intra-arterial chemoembolization improves tumor pathological regression and survival in Borrmann type IV gastric cancer. World J Clin Oncol 2026; In press
PDF 123351-in-press.pdf
Received
2026-05-18 07:41
Peer-Review Started
2026-05-18 07:42
First Decision by Editorial Office Director
Return for Revision
2026-07-13 03:27
Revised
2026-07-27 03:10
Publication Fee Transferred
2026-08-14 08:04
Second Decision by Editor
2026-08-20 02:38
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-08-20 08:42
Articles in Press
2026-08-20 08:42
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2218-4333 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com